Percutaneous treatment of inter-atrial septal defects has undergone exponential growth in
the past 2 decades. Improved percutaneous devices and interventional techniques with low …

The atrial septum is formed by two overlapping embryological structures, the right-sided
muscular septum secundum and the left-sided fibrous septum primum. The foramen ovale is …

Patent foramen ovale (PFO) is a common developmental anomaly that allows for the
passage of blood and other substances from the venous to the arterial circulation. The study …

Objectives: This study evaluated the feasibility of percutaneous patent foramen ovale (PFO)
closure using a transcatheter suture (Superstitch), leaving no device behind. Background …

Background: Percutaneous, mechanical closure of defects of the atrial septum fails to
completely resolve shunting in up to 20% of cases. Little is known about the factors …

Objectives: Our aim was to develop a “standby intracardiac echocardiography” approach to
patent foramen ovale (PFO) closures where intracardiac echocardiography (ICE) is only …

Objectives Transcatheter closure has become one of the main treatment methods for patent
foramen ovale (PFO). However, the population in southern China is generally thin and the …

Objective. The objective of this study was to assess predictors of residual shunts after
percutaneous patent foramen ovale (PFO) closure with Amplatzer PFO occluder (AGA …

Despite the growing recognition of the patent foramen ovale (PFO), particularly when
associated with an atrial septal aneurysm, as risk factor for several disease manifestations …

Background Percutaneous closure represents the first line of treatment in patients with
cryptogenic stroke and documented patent foramen ovale (PFO). Scarce data report the long …